Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Hers Pros Backed by Hims & Hers Health, Inc
GLP-1 Receptor Agonist Market Report Scope & Overview: The GLP-1 Receptor Agonist Market was estimated at USD 60.6 billion in 2025 and is expected to reach USD 307 billion by 2035 and grow at a CAGR of 17.61% over the forecast period of 2026-2035
However, the global supply of these medications remains limited, often resulting in a first-come, first-served distribution
Future directions First, define exposureresponse with quantitative pharmacokinetics and, where possible, receptor-occupancy or target-engagement biomarkers to guide dose selection across tissues
Why This Matters in MCAS Many MCAS patients present with: Abdominal pain with hypersensitivity quality Post-prandial flares IBS-like patterns Burning GI discomfort without structural pathology Persistent symptoms despite antihistamines and mast cell stabilizers In these scenarios, symptoms may reflect mast cellnerve cross-talk rather than uncontrolled mediator release alone
US$ 26.00
US$ 20.53
US$ 26.43
US$ 25.33
US$ 23.35
US$ 27.23
